Related topics cancercolorectal cancernew drugs Advertisement On September 27, 2012, the U.S. Food and Drug Administration (FDA) approved the drug Stivarga to treat advanced cases of colorectal cancer. Colorectal cancer is cancer that starts in the colon or the rectum. Approximately 50% of colon cancer patients will be diagnosed with metastases (cancer that has progressed and spread to other parts of the body). In Connecticut, colorectal cancer is the third leading cause of cancer-related death. Over 600 Connecticut men and women died from colorectal cancer in 2005. The 5-year relative survival rate for patients diagnosed with colorectal cancer in Connecticut is about 65%. Stivarga is a...
0 Responses to FDA approves new drug for advanced colorectal cancer